Sebi Wednesday ordered recovery proceedings against Cell Industries and its two directors for failing to repay the amount along with interest to the investors as directed earlier by the regulator.
"In the interest of investors... direct that recovery proceedings be immediately initiated against CIL (Cell Industries Ltd) and its directors," said the Securities and Exchange Board of India (Sebi) in an order.
The regulator in an earlier order had said that the company and its directors had issued redeemable preference shares (RPS) and non convertible debentures (NCD) in contravention of Sebi norms during 2016.
It had directed the firm and its directors to refund the amount to the investors along with the interest and after completing the repayments, the company shall file a certificate of such completion with Sebi within a period of three months and get it reviewed by two independent Chartered Accountants (CAs).
However, the entities failed to provide the certificates as required, said Sebi.
Moreover, the regulator found that interest was not paid to the investors, as directed in the earlier order and some of the investors had filed writ petition before Calcutta High Court against the firm and its directors as they are yet to receive money from the company.
"The company and its two directors are just engaging Sebi in correspondence with the idea of delaying and protracting compliance with the final order," said Sebi and thereby ordered recovery proceedings against them.
Disclaimer: No Business Standard Journalist was involved in creation of this content
You’ve reached your limit of {{free_limit}} free articles this month.
Subscribe now for unlimited access.
Already subscribed? Log in
Subscribe to read the full story →
Smart Quarterly
₹900
3 Months
₹300/Month
Smart Essential
₹2,700
1 Year
₹225/Month
Super Saver
₹3,900
2 Years
₹162/Month
Renews automatically, cancel anytime
Here’s what’s included in our digital subscription plans
Exclusive premium stories online
Over 30 premium stories daily, handpicked by our editors


Complimentary Access to The New York Times
News, Games, Cooking, Audio, Wirecutter & The Athletic
Business Standard Epaper
Digital replica of our daily newspaper — with options to read, save, and share


Curated Newsletters
Insights on markets, finance, politics, tech, and more delivered to your inbox
Market Analysis & Investment Insights
In-depth market analysis & insights with access to The Smart Investor


Archives
Repository of articles and publications dating back to 1997
Ad-free Reading
Uninterrupted reading experience with no advertisements


Seamless Access Across All Devices
Access Business Standard across devices — mobile, tablet, or PC, via web or app
